Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Net Sales
86.92
Other Operating Income
0.00
Total Operating income
86.92
Raw Material Cost
65.23
Purchase of Finished goods
0.00
(Increase) / Decrease In Stocks
-8.61
Employee Cost
6.85
Power Cost
0.00
Manufacturing Expenses
-0.01
Selling and Distribution Expenses
0.00
Other Expenses
7.29
Total Expenditure (Excl Depreciation)
70.75
Operating Profit (PBDIT) excl Other Income
16.17
Other Income
2.51
Operating Profit (PBDIT)
18.68
Interest
4.63
Exceptional Items
0.00
Gross Profit (PBDT)
14.05
Depreciation
2.89
Profit Before Tax
11.16
Tax
3.39
Provisions and contingencies
0.00
Profit After Tax
7.77
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
7.77
Share in Profit of Associates
0.00
Minority Interest
0.00
Other related items
0.00
Consolidated Net Profit
7.77
Equity Capital
18.45
Face Value
100.0
Reserves
0.00
Earnings per share (EPS)
42.11
Diluted Earnings per share
42.07
Operating Profit Margin (Excl OI)
18.6%
Gross Profit Margin
16.16%
PAT Margin
8.94%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Half Yearly Analysis Highlights
Analysis not available as Data has been published for only 1 period
Compare Half Yearly Results Of Sai Parenteral's With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
86.92
632.69
-545.77
-86.26%
Other Operating Income
0.00
0.00
0.00
Total Operating income
86.92
632.69
-545.77
-86.26%
Raw Material Cost
65.23
314.83
-249.60
-79.28%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-8.61
-14.36
5.75
40.04%
Employee Cost
6.85
108.50
-101.65
-93.69%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
7.29
131.97
-124.68
-94.48%
Total Expenditure (Excl Depreciation)
70.75
540.94
-470.19
-86.92%
Operating Profit (PBDIT) excl Other Income
16.17
91.75
-75.58
-82.38%
Other Income
2.51
1.47
1.04
70.75%
Operating Profit (PBDIT)
18.68
93.22
-74.54
-79.96%
Interest
4.63
44.73
-40.10
-89.65%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
14.05
48.49
-34.44
-71.02%
Depreciation
2.89
48.07
-45.18
-93.99%
Profit Before Tax
11.16
0.42
10.74
2,557.14%
Tax
3.39
0.00
3.39
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
7.77
0.42
7.35
1,750.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
7.77
0.42
7.35
1,750.00%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
7.77
0.42
7.35
1,750.00%
Equity Capital
18.45
44.47
-26.02
-58.51%
Face Value
100.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
42.11
0.09
42.02
46,688.89%
Diluted Earnings per share
42.07
0.10
41.97
41,970.00%
Operating Profit Margin (Excl OI)
18.60%
14.50%
0.00
4.10%
Gross Profit Margin
16.16%
7.66%
0.00
8.50%
PAT Margin
8.94%
0.07%
0.00
8.87%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 86.92 Cr
in Sep 2025Figures in Cr
Half Yearly - Consolidate Net Profit
Consolidate Net Profit 7.77 Cr
in Sep 2025Figures in Cr
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.17 Cr
in Sep 2025Figures in Cr
Half Yearly - Interest
Interest 4.63 Cr
in Sep 2025Figures in Cr
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.60%
in Sep 2025Figures in %






